PPMD Applauds FDA Decision to Expand ELEVIDYS Label for Ages Four Years and Older

WASHINGTON, June 20, 2024 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), applauds the U.S. Food and Drug Administration (FDA) for its decision to expand the labeled indication for…